Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjan Gower

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 18, 2026
Safety FirstDrew Moghanaki, Arjan Gower
Translational Cancer Research|January 16, 2023
Pembrolizumab in advanced non-small cell lung cancer: safety implications of dose adjustmentsArjan Gower, Edward B Garon
Med (New York, N.Y.)|May 19, 2022
Targeting more precisely: Improving sensitivity to EGFR inhibitors in NSCLCArjan Gower, Edward B Garon
Journal of Molecular Medicine (Berlin, Germany)|May 24, 2014
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancerArjan Gower, Yisong Wang, Giuseppe Giaccone
Clinical Lung Cancer|November 11, 2020
Three Primary Tumors Including EGFR-mutated Non-Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni SyndromeArjan Gower, Jong Kim, Kellie Spector, et al.
JCO Precision Oncology|September 14, 2020
Novel <i>ALK</i> Fusion, <i>PPFIBP1-ALK</i>, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and LorlatinibArjan Gower, Barry Golestany, Jun Gong, et al.
Molecular Oncology|December 8, 2015
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancerArjan Gower, Wei-Hsun Hsu, Shuo-Tse Hsu, et al.
Oncotarget|April 15, 2016
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinomaRong An, Yisong Wang, Donna Voeller, et al.
JCO Precision Oncology|September 10, 2025
Identification of Targetable <i>EGFR</i> Mutations in Ovarian CancerArjan Gower, Susan Win, Rituparna Ganguly, et al.
Advances in Radiation Oncology|May 27, 2024
Effectiveness of Single-Fraction, Low-Dose, Bilateral Whole Lung Radiation Therapy for Diffuse Alveolar Hemorrhage Secondary to Extramedullary Hematopoiesis: A Case Report and Review of the LiteratureBeth K Neilsen, Richard L Sleightholm, Arjan Gower, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Journal of Radiation Oncology, Biology, Physics|April 18, 2026
Safety FirstDrew Moghanaki, Arjan Gower
Translational Cancer Research|January 16, 2023
Pembrolizumab in advanced non-small cell lung cancer: safety implications of dose adjustmentsArjan Gower, Edward B Garon
Med (New York, N.Y.)|May 19, 2022
Targeting more precisely: Improving sensitivity to EGFR inhibitors in NSCLCArjan Gower, Edward B Garon
Journal of Molecular Medicine (Berlin, Germany)|May 24, 2014
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancerArjan Gower, Yisong Wang, Giuseppe Giaccone
Clinical Lung Cancer|November 11, 2020
Three Primary Tumors Including EGFR-mutated Non-Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni SyndromeArjan Gower, Jong Kim, Kellie Spector, et al.
JCO Precision Oncology|September 14, 2020
Novel <i>ALK</i> Fusion, <i>PPFIBP1-ALK</i>, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and LorlatinibArjan Gower, Barry Golestany, Jun Gong, et al.
Molecular Oncology|December 8, 2015
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancerArjan Gower, Wei-Hsun Hsu, Shuo-Tse Hsu, et al.
Oncotarget|April 15, 2016
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinomaRong An, Yisong Wang, Donna Voeller, et al.
JCO Precision Oncology|September 10, 2025
Identification of Targetable <i>EGFR</i> Mutations in Ovarian CancerArjan Gower, Susan Win, Rituparna Ganguly, et al.
Advances in Radiation Oncology|May 27, 2024
Effectiveness of Single-Fraction, Low-Dose, Bilateral Whole Lung Radiation Therapy for Diffuse Alveolar Hemorrhage Secondary to Extramedullary Hematopoiesis: A Case Report and Review of the LiteratureBeth K Neilsen, Richard L Sleightholm, Arjan Gower, et al.
Pageof 2